Trial · NCT07903155
Clinical and Radiographic Evaluation of Silver Diamine Fluoride Versus Light-Cured Silver Diamine Fluoride in Carious Primary Molars
NCT07903155, Not applicable, Not yet recruiting, Cairo University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Clinical and Radiographic Evaluation of Silver Diamine Fluoride Versus Light-Cured Silver Diamine Fluoride in Carious Primary Molars. Trials, record NCT07903155. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07903155
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Clinical and Radiographic Evaluation of Silver Diamine Fluoride Versus Light-Cured Silver Diamine Fluoride in Carious Primary Molars
- NCT number
- NCT07903155
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 40 participants, estimated
- Lead sponsor
- Cairo University
- Conditions
- Dental Caries
- Interventions
- Silver diamine Fluoride 38%, LED light curing
- First posted
- 2026-10-29
- Last updated
- 2026-10-29
Source ClinicalTrials.gov
Registered outcomes10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Postoperative pain | At baseline and at 3, 6, 9, and 12 months after treatment. | Postoperative pain will be assessed using a visual analogue scale (VAS) ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst pain. |
| Secondary | Caries lesion arrest | At baseline and at 3, 6, 9, and 12 months after treatment. | Assessment of whether the carious lesion has arrested (yes/no). |
| Secondary | Caries lesion severity (ICDAS) | At baseline and at 3, 6, 9, and 12 months after treatment. | Assessment of caries lesion severity using ICDAS scores 3-6. |
| Secondary | Caries lesion activity (Nyvad criteria) | At baseline and at 3, 6, 9, and 12 months after treatment. | Assessment of lesion activity using Nyvad criteria scores 0-9. |
| Secondary | Soft-tissue pathology | At baseline and at 3, 6, 9, and 12 months after treatment. | Presence or absence of swelling, sinus tract, or fistula. |
| Secondary | Pain on percussion | At baseline and at 3, 6, 9, and 12 months after treatment. | Presence or absence of pain on percussion. |
| Secondary | Pathological tooth mobility | At baseline and at 3, 6, 9, and 12 months after treatment. | Presence or absence of pathological mobility. |
| Secondary | Furcation or periapical radiolucency | At baseline, 6 months, and 12 months after treatment. | Presence or absence of furcation or periapical radiolucency on radiographic examination. |
| Secondary | Widening of the periodontal ligament space | At baseline, 6 months, and 12 months after treatment. | Presence or absence of widening of the periodontal ligament space on radiographic examination. |
| Secondary | Internal or external root resorption | At baseline, 6 months, and 12 months after treatment. | Presence or absence of internal or external root resorption on radiographic examination. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07903155
GET https://conductscience.org/api/trials/v1/NCT07903155/registered